uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Post-hoc analyses of darapladib, an oral Lp-PLA(2) inhibitor, in phase III cardiovascular outcomes trials may inform investigation in diabetic macular edema
GlaxoSmithKline, Worldwide Epidemiol, Collegeville, PA USA..
GlaxoSmithKline, Ophthalmol Res & Dev, Philadelphia, PA USA..
Bogier Clin & IT Solut Inc, Raleigh, NC USA..
GlaxoSmithKline, Quantitat Sci, Philadelphia, PA USA..
Show others and affiliations
2015 (English)In: Investigative Ophthalmology and Visual Science, ISSN 0146-0404, E-ISSN 1552-5783, Vol. 56, no 7Article in journal, Meeting abstract (Other academic) PublishedText
Place, publisher, year, edition, pages
2015. Vol. 56, no 7
National Category
URN: urn:nbn:se:uu:diva-269154ISI: 000362882205283OAI: oai:DiVA.org:uu-269154DiVA: diva2:882618
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), MAY 03-07, 2015, Denver, CO
Available from: 2015-12-15 Created: 2015-12-14 Last updated: 2015-12-15Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Wallentin, Lars
By organisation
UCR-Uppsala Clinical Research CenterCardiology
In the same journal
Investigative Ophthalmology and Visual Science

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 54 hits
ReferencesLink to record
Permanent link

Direct link